RAD51B provides instructions for a protein that helps fix broken DNA. This gene plays an important role in accurate DNA repair, especially when cells copy their DNA before dividing. When RAD51B doesn’t work well, DNA damage can build up, which may make cells more likely to become cancerous. Some inherited variants in the RAD51B gene are linked to a higher risk of breast cancer and, in some families, ovarian cancer, but risk varies by the specific variant and family history.
What is a gene?
A gene is a stretch of DNA that carries instructions your cells use to make molecules or regulate activities in the body. In some genes, those instructions are used to produce proteins, which act as key working components inside cells. In other genes, the main role is to help manage when certain processes happen, where they take place, and how strongly they occur. Taken together, genes affect how your body grows and works, and they can also influence how you react to food, stress, or medications. For a deeper look at this subject, you can find more information in the LearnHub.
Overview
RAD51BGene function
What if the gene works
The RAD51B gene helps cells fix broken DNA using a careful repair pathway called homologous recombination. This supports genome stability during normal cell division and after everyday stresses like sunlight or some chemicals.
Risk
What if the gene does not work
When RAD51B does not work well, DNA damage can build up and may increase the chance of certain cancers, especially breast and ovarian cancer. Changes range from milder variants to severe mutations, influencing risk level and age of onset.
Treatment
What does that mean for your treatment
Pathogenic RAD51B gene variants can make some cancers more responsive to platinum chemotherapy and PARP inhibitors, especially when the tumor shows homologous recombination deficiency. Clinicians usually confirm this with tumor profiling alongside germline results.
Gene function
What if the gene works
Every day, your cells face small amounts of DNA wear and tear as they grow and divide. Across many tissues, the RAD51B gene contributes to steady, routine cell activity by supporting careful DNA repair. This helps keep each cell’s genetic instructions consistent from one cell generation to the next.
One important RAD51B gene function is helping your cells repair double strand DNA breaks (when both DNA strands are broken). It supports a careful repair method that uses a matching DNA copy as a template so the sequence can be restored accurately.
The RAD51B gene works as part of a larger DNA repair team that prepares damaged DNA for fixing. It helps key repair proteins gather at the right spot so the cell can start the repair process efficiently.
By supporting accurate DNA repair, the RAD51B gene helps keep chromosomes stable during cell division. This supports orderly passing of DNA to new cells, which is important for normal growth and tissue upkeep.
What is a variant?
A genetic variant is a minor difference in the DNA code within a gene. These differences are widespread and are part of normal human variation, including things like appearance, metabolism, and how your body reacts to environmental factors. Many variants do not cause any obvious changes and are simply a natural part of genetic diversity. In certain situations, though, a variant can affect how a gene works more strongly and may play a role in, or lead to, a genetic condition.
Genetic variants
What if the gene does not work
Changes in the RAD51B gene can reduce how well cells fix everyday DNA damage, which can let more errors build up over time. Some RAD51B gene variants are milder and may only slightly shift cancer risk, while other RAD51B gene mutation changes can more clearly disrupt the protein and have a stronger effect. This range can influence which health features show up, how severe they are, and, in some cases, how early they appear. A higher risk does not mean a diagnosis.
How variants are linked to conditions
Some inherited changes in the RAD51B gene are linked to a higher risk of certain cancers, especially breast cancer, and they may also be associated with ovarian cancer in some families. This is why RAD51B is sometimes included on hereditary cancer genetic test panels. In this context, the phrase “RAD51B gene mutation and breast cancer risk” refers to a tendency seen in studies, not a guarantee that cancer will develop, and the exact risk depends on the specific variant.
A variant is not necessarily a diagnosis
Differences in DNA are an expected feature of human biology, and they are widespread across the general population. In most situations, these variants do not directly change your health and instead represent normal human diversity. For many genes, having a variant that has been linked to a condition signals a possible connection rather than a certain diagnosis, particularly when risk is shaped by multiple genes along with environmental factors. In other situations, though, one well-studied variant in a particular gene may be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
With a harmful change in the RAD51B gene, your overall cancer risk can still be shaped by other factors, especially family history, age, and whether there are changes in other cancer-related genes. There is not enough evidence to say that specific lifestyle changes reliably lower risk in RAD51B carriers. Even so, keeping a healthy weight, limiting alcohol, and avoiding smoking supports overall health and may lower cancer risk in general.
Inheritance of RAD51B variants
Changes in the RAD51B gene are most often inherited in an autosomal dominant pattern, meaning one changed copy can be enough to increase cancer risk. This explains how RAD51B gene variants are inherited in families: a parent with a RAD51B variant has a 50% chance of passing it to each child. People of any sex can inherit and pass on the variant.
What does my RAD51B result mean for my family?
If you or a close relative has had breast or ovarian cancer, or several family members have had these cancers at younger ages, talk with a clinician or genetics professional about what a RAD51B result could mean for your family. Get medical advice sooner if a RAD51B result is causing strong worry, or if you’re unsure which relatives might benefit from learning the result. In some situations, a RAD51B result can also help guide choices about screening and, for certain cancers, treatment options.
Genetic information
Genetic testing
How you find out about variants
Genetic testing can show whether you carry a change in the RAD51B gene, often via RAD51B genetic testing for cancer risk done as part of a multigene panel. A lab reads DNA from a blood draw or saliva sample and compares it with a reference sequence. Results may be negative, uncertain, or pathogenic.
When should I consider getting a genetic test?
Consider RAD51B genetic testing if you or relatives have had breast or ovarian cancer, especially at a young age or in more than one family member. It can also help if a relative already has a RAD51B change, or if your cancer testing suggests a problem in how cells fix DNA damage. Results can guide screening and planning for relatives.
A genetic result is only one part of your health story
A genetic test result can be very informative, but its usefulness varies based on the health condition and the kind of variant that is found. How your body functions and changes over time is also shaped by factors like lifestyle, environment, age, and your medical history. For some conditions, particularly those shaped by many genes, genetic information helps with understanding but does not provide certainty and makes the most sense when considered together with other parts of care. In other situations, a genetic finding can give a definite explanation. When it comes to how people respond to medications, genetic results can also help put personal experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines, but the RAD51B gene is not a standard pharmacogenetic marker used to guide medication choice. In general, small inherited differences in genes can change how quickly your body breaks down a drug, how strongly a drug reaches its target, or how sensitive you are to side effects. This is one reason the same dose can work well for one person yet feel too strong, too weak, or cause different side effects in another. Pharmacogenetics is the field that studies these patterns so treatment can be better matched to the individual.
What is Pharmacogenetics?
Pharmacogenetics focuses on how inherited genetic differences can affect the way you respond to medications. It examines links between particular genes and specific drugs to explain why the same treatment may not have the same effect in every person. With many medicines, genes can influence how powerfully a drug works or how your body breaks it down. This information can support more informed, individualized decisions about treatment. More details on this topic are available in the LearnHub.
Drugs influenced by the RAD51B gene
When should I seek medical advice?
Seek medical advice if you or close relatives have had breast or ovarian cancer, especially at a young age, or if cancer has occurred in several family members, because RAD51B can be linked to inherited cancer risk. Also talk with a clinician if you already know you carry a RAD51B change and you’re unsure about the right screening plan. Get urgent care for any new breast lump, nipple changes, unusual bleeding, or ongoing pelvic pain.
History
The RAD51B gene entered the research literature in the 1990s as scientists were mapping a group of RAD51 related human genes involved in DNA repair, and it was initially described under names such as RAD51L1. As medical science evolved, so did understanding of this gene. Over the following years, RAD51B was studied alongside other RAD51 “paralogs” (closely related genes) as researchers clarified how this family fits into inherited stability of DNA. In the 2010s, large population studies linked common RAD51B gene variants to small shifts in risk for certain cancers, including breast cancer, helping move the gene into more routine genetics discussions. More recently, RAD51B has also appeared in reports of rare, potentially harmful variants found during multi gene panel testing, supporting ongoing work to define which specific changes are clinically meaningful.